ReportReserve Research's ""Daiichi Sankyo Company, Ltd: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report"" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ReportReserve Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope
- Examines and identifies key information and issues about ""Daiichi Sankyo Company, Ltd"" for business intelligence requirements.
- Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
- Provides data on company financial performance and competitive benchmarking.
- The profile also contains information on business operations, company history, major products and services, prospects, key employees, locations and subsidiaries.

Key Highlights
Daiichi Sankyo Company, Ltd (Daiichi Sankyo) is a holding company, based in Japan. The company is focused on research, development, manufacture and marketing of pharmaceutical products. The company's business operations are classified into two divisions: Pharmaceuticals and Others. The company's Pharmaceuticals division manufactures and markets prescription drug, over-the-counter (OTC) drugs and quasidrugs. The company under its Others division is also involved in the real estate leasing, insurance agency business, and provision for human affairs and accounting services. The company manages a pool of 2,300 overseas medical representatives and thereby catering its products and services in 33 locations, including Japan, North America, Europe and India. The company, founded in 2005, is headquartered in Tokyo, Japan."